Cystic fibrosis
Spinal muscular atrophy
Sickle cell disease
Alpha thalassemia
Beta thalassemia
Trisomy 21
Trisomy 13
Trisomy 18
Sex chromosome aneuploidy
D for RhD negative patients
C, c, D, E, Duffy (Fya), or Kell (K) for alloimmunized patients
Paternal sample not needed for prenatal genetic screening
Fetal risk assessment automatically provided for maternal carriers
Results of genetic carrier screening are available in 7-10 days
One-time payment and one draw, most insurances accepted
Paternal sample required for genetic screening tests
Only the couple's reproductive risk can be provided, not a fetal risk
Results of carrier genetic testing are available within 4-6 weeks and dependent on collecting both parental samples
Multiple payments and appointments carrier screening for genetic conditions
© 2022 Billion to One. All rights reserved.
Assess fetal risk for recessive and chromosomal conditions. Optional fetal RhD status for RhD negative patients; optional red blood cell antigens C, c, D, E, Duffy (Fya), or Kell (K) for alloimmunized patients
Call us now:
For new patients interested in learning more about UNITY, please reach out below.
An aneuploidy NIPT test and maternal carrier screening for recessive conditions are performed from one maternal blood sample. If mom is a carrier, a single-gene NIPT blood test (sgNIPT) is automatically performed to assess fetal risk using the same sample. UNITY is a screening test. Any high-risk result should be followed up with diagnostic testing.
New
Recessive
Cystic fibrosis
Spinal muscular atrophy
Sickle cell disease
Alpha thalassemias
Beta thalassemias
Aneuploidy
Trisomy 21
Trisomy 18
Trisomy 13
Sex chromosome aneuploidy
D for RhD negative patients
C, c, D, E, Duffy (Fya), or Kell (K) for alloimmunized patients
Fetal Antigens (Add on)
For healthcare providers, reach out below and we'll provide a UNITY kit to your clinic at no cost.